249 results on '"Peng, Baogang"'
Search Results
2. YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice
3. A novel nomogram based on preoperative parameters to predict posthepatectomy liver failure in patients with hepatocellular carcinoma
4. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma
5. Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma
6. Microvascular Invasion Status and Its Survival Impact in Hepatocellular Carcinoma Depend on Tissue Sampling Protocol
7. Regional liver function analysis with gadoxetic acid–enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC
8. Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A
9. Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
10. Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery
11. Supplementary Figure from Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
12. Data from Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
13. Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy
14. The prognostic value of neuromedin U in patients with hepatocellular carcinoma
15. Vitamin B6 Metabolic Pathway is Involved in the Pathogenesis of Liver Diseases via Multi-Omics Analysis
16. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1–5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study
17. Supplementary Data from Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma
18. Table S9 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
19. Figure S1-S17 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
20. Potential Common Molecular Mechanisms Between Periodontitis and Hepatocellular Carcinoma: A Bioinformatic Analysis and Validation
21. Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
22. Intracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by Apatinib
23. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment
24. A modified method for isolating mouse islets of an adequate quality, quantity, and purity
25. Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
26. Additional file 1 of Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma
27. Toripalimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma: A single-arm phase II study.
28. Somatic Mutation Profiles Revealed by Next Generation Sequencing (NGS) in 39 Chinese Hepatocellular Carcinoma Patients
29. Senescence Reprograming Drived by Polybromo-1 Deficiency Promotes Intrahepatic Cholangiocarcinoma Progression
30. Genomic Characteristics, Metabolic Signature and Immune Microenvironment of Clonorchis Sinensis-Related Intrahepatic Cholangiocarcinoma
31. Two-wave mixing of ion-implanted photorefractive waveguides in near-stoichiometric Fe:LiNbO 3 crystals
32. METTL1 promotes hepatocarcinogenesis via m 7 G tRNA modification‐dependent translation control
33. Abnormal Bile Acid-Microbiota Crosstalk Promotes the Development of Hepatocellular Carcinoma
34. Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma
35. N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression
36. Salvage resection for recurrent hepatocellular carcinoma after percutaneous ablation therapy: Old therapy served as new strategy: EFP6
37. Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
38. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway
39. Three‐day postoperative antibiotics reduces post‐hepatectomy infection rate in hepatitis B virus‐related hepatocellular carcinoma
40. A Signature of Seven Lipid Metabolism Genes to Predict Hepatocellular Carcinoma Prognosis
41. Six Metabolism Related mRNAs Predict the Prognosis of Patients With Hepatocellular Carcinoma
42. Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma
43. The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinoma
44. IDDF2020-ABS-0189 Clinical analysis of LAPS in the treatment of hepatitis b virus-related hepatocellular carcinoma
45. IDDF2020-ABS-0064 Three-Day Postoperative Antimicrobial Prophylaxis Can Reduce the Incidence of Postoperative Infection in Primary Hepatocellular Carcinoma: A Multicenter Retrospective Study
46. Hepatectomy Provides Good Long-Term Outcomes for Hepatocellular Carcinoma Patients With Portal Hypertension: A Propensity Score Matching Analysis
47. GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma
48. The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
49. Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study
50. Evaluation of Different Blood Circulating miRNAs for Hepatocellular Carcinoma Diagnosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.